West Virginia has joined Arkansas, Missouri, New Mexico and the District of Columbia in an antitrust lawsuit against six drug manufacturers.
The defendants in the multistate case are accused of violating antitrust laws, including the West Virginia Antitrust Act. The Act outlaws contracts or conspiracies that might fix, control or maintain market prices of any commodity or service.
The lawsuit follows an investigation focusing on the reasons behind price increases of certain generic pharmaceuticals. The investigation allegedly found evidence of price fixing for doxycycline hyclate delayed release, a popular antibiotic, and glyburide, an oral diabetes medication.
The defendants include Mylan Pharmaceuticals, Heritage Pharmaceuticals, Aurobindo Pharma USA, Citron Pharma, Mayne Pharma, and Teva Pharmaceuticals.
West Virginia seeks the reimbursement of civil penalties, costs and attorney fees among other monetary relief.
Appalachia Health News is a project of West Virginia Public Broadcasting, with support from the Benedum Foundation, Charleston Area Medical Center and WVU Medicine.